BETA DRUGS
Back to Income Statement
|
BETA DRUGS Last 5 Year Profit Before Tax History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹57 Cr | ₹49 Cr | ₹41 Cr | ₹34 Cr | ₹16 Cr |
What is the latest Profit Before Tax of BETA DRUGS ?
| Year | Profit Before Tax |
|---|---|
| Mar2025 | ₹57 Cr |
| Mar2024 | ₹49 Cr |
| Mar2023 | ₹41 Cr |
| Mar2022 | ₹34 Cr |
| Mar2021 | ₹16 Cr |
How is Profit Before Tax of BETA DRUGS Trending?
| Years | Profit Before Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹57 Cr | 16.85 | |
| Mar2024 | ₹49 Cr | 18.75 | |
| Mar2023 | ₹41 Cr | 19.70 | |
| Mar2022 | ₹34 Cr | 115.04 | |
| Mar2021 | ₹16 Cr | - | |
Compare Profit Before Tax of peers of BETA DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BETA DRUGS | ₹2,796.0 Cr | 12.9% | 26.1% | 39.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹466,431.0 Cr | -2.3% | 3% | 12.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹220,115.0 Cr | 2.9% | 22.7% | 25.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,853.0 Cr | -2.7% | 2% | 33.9% | Stock Analytics | |
| CIPLA | ₹119,158.0 Cr | 0.1% | 3% | -7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.4 Cr | 2.4% | -12.9% | -9.1% | Stock Analytics | |
BETA DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BETA DRUGS | 12.9% |
26.1% |
39.3% |
| SENSEX | 1.3% |
1% |
-2.9% |
You may also like the below Video Courses